A Population-Based Evaluation of a Publicly Funded, School-Based HPV Vaccine Program in British Columbia, Canada: Parental Factors Associated with HPV Vaccine Receipt
Background:
Information on factors that influence parental decisions for actual human papillomavirus (HPV) vaccine receipt in publicly funded, school-based HPV vaccine programs for girls is limited. We report on the level of uptake of the first dose of the HPV vaccine, and determine parental factors associated with receipt of the HPV vaccine, in a publicly funded school-based HPV vaccine program in British Columbia, Canada.
Methods and Findings:
All parents of girls enrolled in grade 6 during the academic year of September 2008–June 2009 in the province of British Columbia were eligible to participate. Eligible households identified through the provincial public health information system were randomly selected and those who consented completed a validated survey exploring factors associated with HPV vaccine uptake. Bivariate and multivariate analyses were conducted to calculate adjusted odds ratios to identify the factors that were associated with parents' decision to vaccinate their daughter(s) against HPV. 2,025 parents agreed to complete the survey, and 65.1% (95% confidence interval [CI] 63.1–67.1) of parents in the survey reported that their daughters received the first dose of the HPV vaccine. In the same school-based vaccine program, 88.4% (95% CI 87.1–89.7) consented to the hepatitis B vaccine, and 86.5% (95% CI 85.1–87.9) consented to the meningococcal C vaccine. The main reasons for having a daughter receive the HPV vaccine were the effectiveness of the vaccine (47.9%), advice from a physician (8.7%), and concerns about daughter's health (8.4%). The main reasons for not having a daughter receive the HPV vaccine were concerns about HPV vaccine safety (29.2%), preference to wait until the daughter is older (15.6%), and not enough information to make an informed decision (12.6%). In multivariate analysis, overall attitudes to vaccines, the impact of the HPV vaccine on sexual practices, and childhood vaccine history were predictive of parents having a daughter receive the HPV vaccine in a publicly funded school-based HPV vaccine program. By contrast, having a family with two parents, having three or more children, and having more education was associated with a decreased likelihood of having a daughter receive the HPV vaccine.
Conclusions:
This study is, to our knowledge, one of the first population-based assessments of factors associated with HPV vaccine uptake in a publicly funded school-based program worldwide. Policy makers need to consider that even with the removal of financial and health care barriers, parents, who are key decision makers in the uptake of this vaccine, are still hesitant to have their daughters receive the HPV vaccine, and strategies to ensure optimal HPV vaccine uptake need to be employed.
: Please see later in the article for the Editors' Summary
Vyšlo v časopise:
A Population-Based Evaluation of a Publicly Funded, School-Based HPV Vaccine Program in British Columbia, Canada: Parental Factors Associated with HPV Vaccine Receipt. PLoS Med 7(5): e32767. doi:10.1371/journal.pmed.1000270
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000270
Souhrn
Background:
Information on factors that influence parental decisions for actual human papillomavirus (HPV) vaccine receipt in publicly funded, school-based HPV vaccine programs for girls is limited. We report on the level of uptake of the first dose of the HPV vaccine, and determine parental factors associated with receipt of the HPV vaccine, in a publicly funded school-based HPV vaccine program in British Columbia, Canada.
Methods and Findings:
All parents of girls enrolled in grade 6 during the academic year of September 2008–June 2009 in the province of British Columbia were eligible to participate. Eligible households identified through the provincial public health information system were randomly selected and those who consented completed a validated survey exploring factors associated with HPV vaccine uptake. Bivariate and multivariate analyses were conducted to calculate adjusted odds ratios to identify the factors that were associated with parents' decision to vaccinate their daughter(s) against HPV. 2,025 parents agreed to complete the survey, and 65.1% (95% confidence interval [CI] 63.1–67.1) of parents in the survey reported that their daughters received the first dose of the HPV vaccine. In the same school-based vaccine program, 88.4% (95% CI 87.1–89.7) consented to the hepatitis B vaccine, and 86.5% (95% CI 85.1–87.9) consented to the meningococcal C vaccine. The main reasons for having a daughter receive the HPV vaccine were the effectiveness of the vaccine (47.9%), advice from a physician (8.7%), and concerns about daughter's health (8.4%). The main reasons for not having a daughter receive the HPV vaccine were concerns about HPV vaccine safety (29.2%), preference to wait until the daughter is older (15.6%), and not enough information to make an informed decision (12.6%). In multivariate analysis, overall attitudes to vaccines, the impact of the HPV vaccine on sexual practices, and childhood vaccine history were predictive of parents having a daughter receive the HPV vaccine in a publicly funded school-based HPV vaccine program. By contrast, having a family with two parents, having three or more children, and having more education was associated with a decreased likelihood of having a daughter receive the HPV vaccine.
Conclusions:
This study is, to our knowledge, one of the first population-based assessments of factors associated with HPV vaccine uptake in a publicly funded school-based program worldwide. Policy makers need to consider that even with the removal of financial and health care barriers, parents, who are key decision makers in the uptake of this vaccine, are still hesitant to have their daughters receive the HPV vaccine, and strategies to ensure optimal HPV vaccine uptake need to be employed.
: Please see later in the article for the Editors' Summary
Zdroje
1. WalboomersJM
JacobsMV
ManosMM
BoschFX
KummerJA
1999 Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 12 19
2. AultKA
Future II Study Group 2007 Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 369 1861 1868
3. The Future II Study Group 2007 Quadrivalent vaccine against human papillomavirus to prevent high grade cervical lesions. N Engl J Med 356 1915 1927
4. PaavonenJ
JenkinsD
BoschFX
NaudP
SalmeronJ
2007 Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 369 2161 2170
5. JouraEA
LeodolterS
Hernandez-AvilaM
WheelerCM
PerezG
2007 Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials. Lancet 369 1693 1702
6. GuntherOP
OgilvieG
NausM
YoungE
PatrickDM
2008 Protecting the next generation: what is the role of the duration of human papillomavirus vaccine-related immunity? J Infect Dis 197 1653 1661
7. GarnettGP
KimJJ
FrenchK
GoldieSJ
2006 Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes. Vaccine 24 S178 S186
8. GoldieSJ
KimJJ
MyersE
2006 Chapter 19: Cost-effectiveness of cervical cancer screening. Vaccine 24 S164 S170
9. ZimetGD
2005 Improving adolescent health: focus on HPV vaccine acceptance. J Adolesc Health 37 S17 S23
10. DempseyAF
ZimetGD
DavisRL
KoutskyL
2006 Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics 117 1486 1493
11. MarlowLAV
WallerJ
WardleJ
2007 Parental attitudes to pre-pubertal HPV vaccination. Vaccine 25 1945 1952
12. OlshenE
WoodsER
AustinSB
LuskinM
BauchnerH
2005 Parental acceptance of the human papillomavirus vaccine. J Adolesc Health 37 248 251
13. DavisK
DickmanED
FerrisD
DiasJK
2004 Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis 8 188 194
14. OgilvieGS
RempleVP
MarraF
McNeilS
NausM
2007 Parental intention to have daughters receive the human papillomavirus vaccine. Can Med Assoc J 177 1506 1512
15. KahnJA
DingL
HuangB
ZimetGD
RosenthalSL
2009 Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics 123 1439 1445
16. ChristianWJ
ChristianA
HopenhaynC
2009 Acceptance of the HPV vaccine for adolescent girls: analysis of state-added questions from the BRFSS. J Adolesc Health 44 437 445
17. ConstantineNA
JermanP
2007 Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health 40 108 115
18. WoodhallSC
LehtinenM
VerhoT
HuhtalaH
HokkanenM
2007 Anticipated acceptance of HPV vaccination at the baseline of implementation: a survey of parental and adolescent knowledge and attitudes in Finland. J Adolesc Health 40 466 469
19. TriccoAC
AnonychukAM
NgC
PhamB
2007 International acceptability of human papillomavirus vaccines: a systematic review. 24th International Papillomavirus Conference and Clinical Workshop; 3–9 November 2007; Beijing, China
20. BrabinL
RobertsSA
StretchR
BaxterD
ChambersG
2008 Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: a prospective cohort study. BMJ 336 1056
21. HankinsM
FrenchD
HorneR
2000 Statistical guidelines for studies of the theory of reasoned action and the theory of planned behaviour. Psychol Health 15 151 161
22. BC Stats, Government of British Columbia 2007 Population extrapolation for organization planning with less error, run cycle 32. Available: http://www.bcstats.gov.bc.ca/DATA/POP/pop/popproj.asp. Victoria, British Columbia: Ministry of Health, Government of British Columbia. Accessed 15 December 2008
23. RosnerB
2000 Fundamentals of biostatistics. 5th edition Pacific Grove (California) Thomson Higher Education
24. Immunization Program BCfDC 2009 Immunization coverage rates, British Columbia. British Columbia Centre for Disease Control. Available: http://www.bccdc.org. Accessed 15 June 2009
25. DempseyAF
AbrahamLM
DaltonV
RuffinM
2009 Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol 19 531 538
26. RosenthalSL
RuppR
ZimetGD
MezaHM
LozaML
2008 Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health 43 239 245
27. DobsonS
DeeksS
MoneyDM
2007 National Advisory Committee on Immunization Statement on Human Papillomavirus Vaccine. CCDR 33 1 32
28. RacineAD
JoyceTJ
2007 Maternal education, child immunizations, and public policy: evidence from the US National Immunization Survey. Soc Sci Med 65 1765 1772
29. GullionJS
HenryL
GullionG
2008 Deciding to opt out of childhood vaccination mandates. Public Health Nurs 25 401 408
30. SaewycE
TaylorD
HommaY
OgilvieGS
2008 Trends in sexual health and risk behaviours among adolescent students in British Columbia. Can J Hum Sex 17 1 14
31. OmerSB
SalmonDA
OrensteinWA
deHartMP
HalseyN
2009 Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N Engl J Med 360 1981 1988
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2010 Číslo 5
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Self-Injurious Behavior in Adolescents
- Non-Communicable Diseases in Sub-Saharan Africa: The Case for Cohort Studies
- The Malawi Developmental Assessment Tool (MDAT): The Creation, Validation, and Reliability of a Tool to Assess Child Development in Rural African Settings
- Journals, Academics, and Pandemics